Amlodac

Amlodac

amlodipine

Manufacturer:

Zydus Cadila

Distributor:

Pharmadica
Concise Prescribing Info
Contents
Amlodipine besylate
Indications/Uses
1st-line treatment of HTN & MI whether due to fixed obstruction (stable angina) &/or vasospasm/vasoconstriction (Prinzmetal's or variant angina) of coronary vasculature.
Dosage/Direction for Use
Initially 5 mg once daily; may be increased to max 10 mg.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to dihydropyridines.
Special Precautions
Heart failure, impaired liver function.
Adverse Reactions
Headache, edema, fatigue, nausea, abdominal pain, flushing, palpitations, dizziness.
ATC Classification
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
Presentation/Packing
Form
Amlodac tab 5 mg
Packing/Price
10 × 10's
Form
Amlodac tab 10 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in